New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2013
18:59 EDTETRM, CSTR, MCHP, SPWR, NUAN, ATVI, RVBD, UBTI, LNKDOn The Fly: After Hours Movers
UP AFTER EARNINGS: LinkedIn (LNKD), up 10%... Activision Blizzard (ATVI), up 5.4%... Microchip Technology (MCHP), up 6.5%... Ubiquiti Networks (UBTI), up 8.9%... DOWN AFTER EARNINGS: Nuance (NUAN), down 14.5%... Coinstar (CSTR), down 8.5%... Riverbed (RVBD), down 8.8%... SunPower (SPWR), 5%... ALSO LOWER: EnteroMedics (ETRM), down 51% after its ReCharge trial failed to meet an efficacy endpoint.
News For LNKD;ATVI;MCHP;UBTI;NUAN;CSTR;RVBD;SPWR;ETRM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 26, 2015
06:48 EDTSPWRTax credit, loan guarantee changes could hurt solar energy, NY Times says
Subscribe for More Information
January 23, 2015
10:02 EDTLNKDOn the Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AmSurg (AMSG) upgraded to Overweight from Neutral at Piper Jaffray... Anglo American (AAUKY) upgraded to Neutral from Sell at Goldman... Autobytel (ABTL) upgraded to Buy from Hold at Ascendiant... Charles River Labs (CRL) upgraded to Outperform from Market Perform at William Blair... Chesapeake (CHK) upgraded to Outperform from Neutral at Credit Suisse... CubeSmart (CUBE) upgraded to Buy from Neutral at SunTrust... Cypress Semiconductor (CY) upgraded to Neutral from Underweight at JPMorgan... DreamWorks Animation (DWA) upgraded to Overweight from Neutral at Piper Jaffray... E-Trade (ETFC) upgraded at Credit Suisse... Kate Spade (KATE) upgraded to Buy from Neutral at Mizuho... LinkedIn (LNKD) upgraded to Strong Buy from Market Perform at Raymond James... Matthews (MATW) upgraded to Outperform from Neutral at Macquarie... Meridian Bioscience (VIVO) upgraded to Buy from Hold at Craig-Hallum... Michael Kors (KORS) upgraded to Buy from Neutral at Mizuho... NIC Inc. (EGOV) upgraded to Hold from Sell at Maxim... Natural Grocers (NGVC) upgraded to Overweight from Neutral at Piper Jaffray... Nucor (NUE) upgraded to Buy from Neutral at Goldman... ResMed (RMD) upgraded to Buy from Hold at Needham... Smith & Wesson (SWHC) upgraded to Buy from Neutral at Dougherty... Ternium (TX) upgraded to Neutral from Sell at Goldman... Union Pacific (UNP) upgraded to Buy from Hold at BB&T... ZAGG (ZAGG) upgraded to Buy from Hold at Craig-Hallum... lululemon (LULU) upgraded to Overweight from Neutral at JPMorgan.
09:22 EDTLNKDLinkedIn upgraded to Strong Buy from Market Perform at Raymond James
Subscribe for More Information
08:04 EDTSPWRTotal and SunPower complete 70MW Salvador project
Subscribe for More Information
06:45 EDTLNKDLinkedIn upgraded to Strong Buy from Market Perform at Raymond James
Subscribe for More Information
January 20, 2015
16:54 EDTRVBDRiverbed board recommends holders vote for adoption of merger with Thoma Bravo
On December 15, 2014, Riverbed Technology announced that it entered into a definitive agreement to be acquired by leading private equity investment firm Thoma Bravo, LLC and Teachers’ Private Capital, the private investor department of Ontario Teachers’ Pension Plan.
09:38 EDTNUANActive equity options trading
Subscribe for More Information
January 16, 2015
09:12 EDTATVIOn The Fly: Pre-market Movers
Subscribe for More Information
08:03 EDTATVIActivision says Call of Duty: Advanced Warffare was top-selling console game
Subscribe for More Information
05:45 EDTATVIDecember NPD video game software sales dropped 2%, says Piper Jaffray
Piper Jaffray notes December NPD video game software sales fell 2% year-over-year, with the full quarter down 6% and 2014 down 13%. Piper attributes the declines to legacy weakness and a portion of sales shifting to full-game downloads. The firm expects software growth in 2015 and maintains Overweight ratings on Activision Blizzard (ATVI), Electronic Arts (EA), GameStop (GME) and Take-Two (TTWO).
January 14, 2015
14:07 EDTETRMEnteroMedics price target raised to $5 from $4 at Craig-Hallum
Subscribe for More Information
10:39 EDTETRMEnteroMedics confirms FDA approval of VBLOC obesity treatment
Subscribe for More Information
10:27 EDTLNKDFacebook, Google seen at front of 'multi-year' positive run for Internet stocks
Subscribe for More Information
10:21 EDTETRMEnteroMedics obesity device approved by FDA
The FDA approved the Maestro Rechargeable System for certain obese adults, the first weight loss treatment device that targets the nerve pathway between the brain and the stomach that controls feelings of hunger and fullness. The Maestro Rechargeable System, the first FDA-approved obesity device since 2007, is approved to treat patients aged 18 and older who have not been able to lose weight with a weight loss program, and who have a body mass index of 35 to 45 with at least one other obesity-related condition, such as type 2 diabetes. The Maestro Rechargeable System is manufactured by EnteroMedics. As part of the approval, the manufacturer must conduct a five year post approval study that will follow at least 100 patients and collect additional safety and effectiveness data including weight loss, adverse events, surgical revisions and explants and changes in obesity-related conditions.
10:17 EDTETRMEnteroMedics trading halted, pending news

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use